Ramirez, Adriana G.
Wages, Nolan A.
Hu, Yinin
Smolkin, Mark E.
Slingluff, Craig L. Jr.
Funding for this research was provided by:
National Institutes of Health (CA057653, CA118386, CA103528, CA163177, CA181638, CA044579)
Article History
Received: 9 June 2015
Accepted: 10 September 2015
First Online: 21 September 2015
Compliance with ethical standards
:
: Craig Slingluff is an inventor of several peptides included in the vaccine that was administered during the clinical trials studied within this paper. The University of Virginia Licensing and Ventures Group holds the patents for those peptides, which have been licensed through the Ludwig Institute for Cancer Research to Glaxo Smith Kline. The remaining authors have nothing to disclose or competing interests in association with this study.